ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CDXS Codexis Inc

3.95
0.61 (18.26%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Codexis Inc CDXS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.61 18.26% 3.95 23:00:14
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.62 3.53 4.01 3.92 3.34
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:05GLOBECodexis Reports First Quarter 2024 Financial Results
18/4/202415:05GLOBECodexis to Report First Quarter 2024 Financial Results on..
11/4/202406:05GLOBECodexis Appoints Carole Cobb, MBA, to Strategic Advisory..
06/3/202415:02EDGAR2Form 8-K - Current report
28/2/202415:05GLOBECodexis Reports Fourth Quarter and Fiscal Year 2023..
27/2/202411:15APSBiotech Rallied Strongly On Exclusive Licensing Agreement
26/2/202415:05GLOBECodexis Enters Exclusive Licensing Agreement for Newly..
26/2/202407:05GLOBECodexis to Participate in TD Cowen 44th Annual Health Care..
20/2/202407:05GLOBECodexis Announces Appointment of Masad Damha, PhD, and Jim..
16/2/202415:01EDGAR2Form 8-K - Current report
14/2/202415:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:05GLOBECodexis to Report Fourth Quarter and Fiscal Year 2023..
13/2/202415:19EDGAR2Form 8-K - Current report
13/2/202415:05GLOBECodexis Secures $40 Million in Strategic Financing Deal with..
09/2/202415:06EDGAR2Form 8-K - Current report
01/2/202415:05GLOBEseqWell and Codexis to Unveil Engineered Transposase Enzyme..
24/1/202413:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/1/202407:30EDGAR2Form 8-K - Current report
02/1/202420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202307:30GLOBECodexis Announces Purchase Agreement with Nestlé Health..
27/12/202307:30EDGAR2Form 8-K - Current report
13/12/202315:06GLOBECodexis and Aldevron Enter Exclusive Licensing Agreement for..
13/12/202315:05GLOBECodexis Announces Achievement of Gram-scale Synthesis with..
11/12/202306:05GLOBECodexis KOL Event Highlights Significant Need for an..
28/11/202315:05GLOBECodexis to Host Virtual KOL Event on its ECO Synthesis™..
17/11/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202316:31EDGAR2Form 144 - Report of proposed sale of securities
14/11/202315:05GLOBECodexis to Participate in 35th Annual Piper Sandler..
03/11/202315:26EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:16EDGAR2Form 8-K - Current report
02/11/202315:05GLOBECodexis Reports Third Quarter 2023 Financial Results
31/10/202315:05GLOBECodexis to Participate in Upcoming Healthcare Conferences
27/10/202314:35GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
26/10/202315:05GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
19/10/202315:05GLOBECodexis to Report Third Quarter 2023 Financial Results on..
29/9/202306:05GLOBECodexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton..
22/9/202315:32EDGAR2Form 8-K - Current report
18/9/202315:05GLOBECodexis CEO Stephen Dilly Named as Finalist of 2023 Bloom..
12/9/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202315:05GLOBECodexis to Participate in Cantor Global Healthcare..
07/9/202315:05EDGAR2Form 8-K - Current report
07/9/202315:05GLOBECodexis Announces Agreement for Assignment and Assumption of..
03/8/202315:54EDGAR2Form S-8 - Securities to be offered to employees in employee..

Su Consulta Reciente

Delayed Upgrade Clock